Commonwealth Equity Services
LRMR icon

Commonwealth Equity Services’s Larimar Therapeutics LRMR Stock Holding History

Commonwealth Equity Services’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.3K Sell
23,067
-1,715
-7% -$6.81K ﹤0.01% 4282
2026
Q1 		$112K Buy
24,782
+1,934
+8% +$7.73K ﹤0.01% 4116
2025
Q4 		$87K Buy
+22,848
New +$88.9K ﹤0.01% 4127
2024
Q4 		– Sell
-15,348
Closed -$101K – 4164
2024
Q3 		$101K Buy
+15,348
New +$123K ﹤0.01% 3864

Other funds holding LRMR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Commonwealth Equity Services's LRMR Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Larimar Therapeutics (LRMR) stake by 6.9% in Q2 2026, selling an estimated $6.81K and leaving 23,067 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4282.

Commonwealth Equity Services first reported a position in LRMR in Q3 2024 and has held it in 4 quarters since. The position peaked at $112K in Q1 2026. 25 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Commonwealth Equity Services held 23,067 shares of Larimar Therapeutics worth $70.3K as of Q2 2026.
  • Commonwealth Equity Services sold 1,715 Larimar Therapeutics shares in Q2 2026, an estimated $6.81K.
  • Larimar Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4282 holding.
  • Commonwealth Equity Services first reported a position in Larimar Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Commonwealth Equity Services's Larimar Therapeutics position peaked at $112K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.